The less frequent Vδ3+ γδ T cells were shown to recognize and kill CD1d+ target cells (109) and are activated by annexin A2 ligands on tumor cells that are upregulated under oxidative stress conditions (127). The gene discussed is CD1D; the disease is neoplasm.